Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	extracellular matrix	THSD4 PRSS3 RELN ZAN ADAMTS10 S100A8 TGM3 PRG3 PTPRZ1 LPA GPC4 PLAT CLEC3B ADAMTS14 MMP9	9.87e-06	656	126	15	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	THSD4 PRSS3 RELN ZAN ADAMTS10 S100A8 TGM3 PRG3 PTPRZ1 LPA GPC4 PLAT CLEC3B ADAMTS14 MMP9	1.02e-05	658	126	15	GO:0030312
GeneOntologyCellularComponent	collagen-containing extracellular matrix	THSD4 PRSS3 RELN ADAMTS10 S100A8 TGM3 PRG3 PTPRZ1 LPA GPC4 PLAT CLEC3B MMP9	1.94e-05	530	126	13	GO:0062023
GeneOntologyCellularComponent	axonemal dynein complex	DNAH12 DNAI4 DNAH6	4.46e-04	25	126	3	GO:0005858
GeneOntologyCellularComponent	serine protease inhibitor complex	PLAT PLAU	5.32e-04	6	126	2	GO:0097180
MousePheno	decreased susceptibility to induced choroidal neovascularization	LPA PLAT PLAU NOS2	5.64e-07	10	103	4	MP:0003434
MousePheno	choroidal neovascularization	LPA PLAT PLAU NOS2	9.90e-06	19	103	4	MP:0005546
MousePheno	abnormal choroid vasculature morphology	LPA PLAT PLAU NOS2	4.28e-05	27	103	4	MP:0006237
Domain	Kringle-like	MRC1 LPA PLAT PLAU MMP9	2.25e-06	32	126	5	IPR013806
Domain	uDENN	DENND4B DENND2C DENND5A	1.03e-04	14	126	3	SM00800
Domain	uDENN	DENND4B DENND2C DENND5A	1.29e-04	15	126	3	PF03456
Domain	VDCC_T_a1	CACNA1I CACNA1G	1.35e-04	3	126	2	IPR005445
Domain	DENN	DENND4B DENND2C DENND5A	1.57e-04	16	126	3	SM00799
Domain	DENN	DENND4B DENND2C DENND5A	1.57e-04	16	126	3	PF02141
Domain	dDENN	DENND4B DENND2C DENND5A	1.57e-04	16	126	3	PF03455
Domain	UDENN	DENND4B DENND2C DENND5A	1.57e-04	16	126	3	PS50946
Domain	DDENN	DENND4B DENND2C DENND5A	1.57e-04	16	126	3	PS50947
Domain	dDENN	DENND4B DENND2C DENND5A	1.57e-04	16	126	3	SM00801
Domain	dDENN_dom	DENND4B DENND2C DENND5A	1.57e-04	16	126	3	IPR005112
Domain	uDENN_dom	DENND4B DENND2C DENND5A	1.57e-04	16	126	3	IPR005113
Domain	DENN	DENND4B DENND2C DENND5A	1.57e-04	16	126	3	PS50211
Domain	DENN_dom	DENND4B DENND2C DENND5A	1.57e-04	16	126	3	IPR001194
Domain	Kringle_CS	LPA PLAT PLAU	1.90e-04	17	126	3	IPR018056
Domain	Carb_anhydrase	CA12 PTPRG PTPRZ1	1.90e-04	17	126	3	PF00194
Domain	Carb_anhydrase	CA12 PTPRG PTPRZ1	1.90e-04	17	126	3	SM01057
Domain	KRINGLE_1	LPA PLAT PLAU	1.90e-04	17	126	3	PS00021
Domain	-	CA12 PTPRG PTPRZ1	1.90e-04	17	126	3	3.10.200.10
Domain	KR	LPA PLAT PLAU	1.90e-04	17	126	3	SM00130
Domain	Kringle	LPA PLAT PLAU	1.90e-04	17	126	3	IPR000001
Domain	ALPHA_CA_2	CA12 PTPRG PTPRZ1	1.90e-04	17	126	3	PS51144
Domain	KRINGLE_2	LPA PLAT PLAU	1.90e-04	17	126	3	PS50070
Domain	Kringle	LPA PLAT PLAU	1.90e-04	17	126	3	PF00051
Domain	Carbonic_anhydrase_a	CA12 PTPRG PTPRZ1	1.90e-04	17	126	3	IPR001148
Domain	PLAC	THSD4 ADAMTS10 ADAMTS14	2.68e-04	19	126	3	PS50900
Domain	PLAC	THSD4 ADAMTS10 ADAMTS14	2.68e-04	19	126	3	IPR010909
Domain	FN3	OBSCN TYRO3 IL22RA2 PTPRG PTPRZ1 FNDC8 EPHA5	4.07e-04	199	126	7	PS50853
Domain	DOCK_N	DOCK3 DOCK4	4.46e-04	5	126	2	PF16172
Domain	DOCK_N	DOCK3 DOCK4	4.46e-04	5	126	2	IPR032376
Domain	GST_mu	GSTM1 GSTM5	4.46e-04	5	126	2	IPR003081
Domain	ADAM_spacer1	THSD4 ADAMTS10 ADAMTS14	4.81e-04	23	126	3	IPR010294
Domain	ADAM_spacer1	THSD4 ADAMTS10 ADAMTS14	4.81e-04	23	126	3	PF05986
Domain	FN3_dom	OBSCN TYRO3 IL22RA2 PTPRG PTPRZ1 FNDC8 EPHA5	5.45e-04	209	126	7	IPR003961
Domain	Prot-tyrosine_phosphatase-like	DUSP12 MTMR8 PTPRG PTPRZ1 TNS3	5.56e-04	99	126	5	IPR029021
Domain	PTPc_motif	MTMR8 PTPRG PTPRZ1 TNS3	6.75e-04	59	126	4	SM00404
Domain	Tyr_Pase_cat	MTMR8 PTPRG PTPRZ1 TNS3	6.75e-04	59	126	4	IPR003595
Domain	fn3	OBSCN TYRO3 PTPRG PTPRZ1 FNDC8 EPHA5	8.12e-04	162	126	6	PF00041
Domain	FN3	OBSCN TYRO3 PTPRG PTPRZ1 FNDC8 EPHA5	1.61e-03	185	126	6	SM00060
Domain	VDCCAlpha1	CACNA1I CACNA1G	1.96e-03	10	126	2	IPR002077
Domain	-	ADAMTS10 MME ADAMTS14 MMP9	2.20e-03	81	126	4	3.40.390.10
Domain	MetalloPept_cat_dom	ADAMTS10 MME ADAMTS14 MMP9	2.20e-03	81	126	4	IPR024079
Domain	DHR-1_domain	DOCK3 DOCK4	2.39e-03	11	126	2	IPR027007
Domain	DHR_2	DOCK3 DOCK4	2.39e-03	11	126	2	PS51651
Domain	DHR_1	DOCK3 DOCK4	2.39e-03	11	126	2	PS51650
Domain	DHR-2	DOCK3 DOCK4	2.39e-03	11	126	2	PF06920
Domain	DOCK	DOCK3 DOCK4	2.39e-03	11	126	2	IPR026791
Domain	DOCK_C	DOCK3 DOCK4	2.39e-03	11	126	2	IPR010703
Domain	DOCK-C2	DOCK3 DOCK4	2.39e-03	11	126	2	PF14429
Domain	DHR-2	DOCK3 DOCK4	2.39e-03	11	126	2	IPR027357
Domain	TYR_PHOSPHATASE_1	DUSP12 MTMR8 PTPRG PTPRZ1	2.74e-03	86	126	4	PS00383
Domain	ABC_A	ABCA3 ABCA10	2.85e-03	12	126	2	IPR026082
Domain	C-type_lectin_CS	MRC1 PRG3 CLEC3B	3.04e-03	43	126	3	IPR018378
Domain	F-box-like	FBXW12 ECT2L FBXO44	3.24e-03	44	126	3	PF12937
Domain	TTL	TTLL5 TTLL4	3.35e-03	13	126	2	PS51221
Domain	TTL/TTLL_fam	TTLL5 TTLL4	3.35e-03	13	126	2	IPR004344
Domain	-	MRC1 MMP9	3.35e-03	13	126	2	2.10.10.10
Domain	TTL	TTLL5 TTLL4	3.35e-03	13	126	2	PF03133
Domain	-	DUSP12 PTPRG PTPRZ1 TNS3	3.49e-03	92	126	4	3.90.190.10
Domain	Dynein_heavy_chain_D4_dom	DNAH12 DNAH6	3.90e-03	14	126	2	IPR024317
Domain	FN_type2_col-bd	MRC1 MMP9	3.90e-03	14	126	2	IPR000562
Domain	FN2_2	MRC1 MMP9	3.90e-03	14	126	2	PS51092
Domain	Dynein_heavy_dom-2	DNAH12 DNAH6	3.90e-03	14	126	2	IPR013602
Domain	DHC_N2	DNAH12 DNAH6	3.90e-03	14	126	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH12 DNAH6	3.90e-03	14	126	2	IPR011704
Domain	FN2_1	MRC1 MMP9	3.90e-03	14	126	2	PS00023
Domain	PLAC	THSD4 ADAMTS10	3.90e-03	14	126	2	PF08686
Domain	AAA_8	DNAH12 DNAH6	3.90e-03	14	126	2	PF12780
Domain	fn2	MRC1 MMP9	3.90e-03	14	126	2	PF00040
Domain	FN2	MRC1 MMP9	3.90e-03	14	126	2	SM00059
Domain	AAA_5	DNAH12 DNAH6	3.90e-03	14	126	2	PF07728
Domain	PROTEIN_KINASE_TYR	OBSCN TYRO3 ALK EPHA5	4.22e-03	97	126	4	PS00109
Domain	Tyr_kinase_AS	OBSCN TYRO3 ALK EPHA5	4.22e-03	97	126	4	IPR008266
Domain	ZINC_PROTEASE	ADAMTS10 MME ADAMTS14 MMP9	4.38e-03	98	126	4	PS00142
Domain	DHC_fam	DNAH12 DNAH6	4.48e-03	15	126	2	IPR026983
Domain	Dynein_heavy	DNAH12 DNAH6	4.48e-03	15	126	2	PF03028
Domain	Dynein_heavy_dom	DNAH12 DNAH6	4.48e-03	15	126	2	IPR004273
Domain	MAM_1	ZAN ALK	5.09e-03	16	126	2	PS00740
Domain	FBOX	FBXW12 ECT2L FBXO44	5.21e-03	52	126	3	SM00256
Domain	TRYPSIN_HIS	PRSS3 LPA PLAT PLAU	5.22e-03	103	126	4	IPR018114
Domain	DUF1605	DHX33 DHX29	5.75e-03	17	126	2	IPR011709
Domain	OB_NTP_bind	DHX33 DHX29	5.75e-03	17	126	2	PF07717
Domain	TRYPSIN_SER	PRSS3 LPA PLAT PLAU	5.78e-03	106	126	4	PS00135
Domain	TRYPSIN_HIS	PRSS3 LPA PLAT PLAU	5.97e-03	107	126	4	PS00134
Domain	MAM	ZAN ALK	6.44e-03	18	126	2	PF00629
Domain	MAM_dom	ZAN ALK	6.44e-03	18	126	2	IPR000998
Domain	HA2	DHX33 DHX29	6.44e-03	18	126	2	SM00847
Domain	MAM_2	ZAN ALK	6.44e-03	18	126	2	PS50060
Domain	HA2	DHX33 DHX29	6.44e-03	18	126	2	PF04408
Domain	Helicase-assoc_dom	DHX33 DHX29	6.44e-03	18	126	2	IPR007502
Pathway	KEGG_MEDICUS_VARIANT_TMPRSS2_ERG_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION	PLAT PLAU MMP9	1.15e-05	7	99	3	M47443
Pathway	BIOCARTA_FIBRINOLYSIS_PATHWAY	LPA PLAT PLAU	7.06e-05	12	99	3	MM1398
Pathway	BIOCARTA_PLATELETAPP_PATHWAY	LPA PLAT PLAU	1.16e-04	14	99	3	MM1458
Pathway	REACTOME_DISSOLUTION_OF_FIBRIN_CLOT	LPA PLAT PLAU	1.44e-04	15	99	3	MM15450
Pathway	PID_AMB2_NEUTROPHILS_PATHWAY	LPA PLAT PLAU MMP9	1.90e-04	41	99	4	M159
Pubmed	Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.	LPA PLAT PLAU MMP9	2.87e-09	6	131	4	15841177
Pubmed	Fibrinolysis-independent role of plasmin and its activators in the haematopoietic recovery after myeloablation.	LPA PLAT PLAU	2.08e-07	4	131	3	19210287
Pubmed	Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.	PLAT PLAU MMP9	2.08e-07	4	131	3	15631996
Pubmed	Plasmin is essential in preventing periodontitis in mice.	LPA PLAT PLAU	2.08e-07	4	131	3	21704601
Pubmed	Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.	PLAT PLAU MMP9	2.08e-07	4	131	3	14617754
Pubmed	Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling.	PLAT PLAU MMP9	2.08e-07	4	131	3	21802414
Pubmed	Plasminogen activator induction facilitates recovery of respiratory function following spinal cord injury.	LPA PLAT PLAU	2.08e-07	4	131	3	18042398
Pubmed	Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush.	LPA PLAT PLAU	2.08e-07	4	131	3	11404420
Pubmed	Plasmin-mediated proteolysis is required for hepatocyte growth factor activation during liver repair.	LPA PLAT PLAU	2.08e-07	4	131	3	19286661
Pubmed	Beneficial and detrimental effects of plasmin(ogen) during infection and sepsis in mice.	LPA PLAT PLAU	2.08e-07	4	131	3	21931850
Pubmed	Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.	LPA PLAT PLAU	2.08e-07	4	131	3	16763560
Pubmed	Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice.	LPA PLAT MMP9	5.19e-07	5	131	3	17596135
Pubmed	Fibrinolytic crosstalk with endothelial cells expands murine mesenchymal stromal cells.	LPA PLAT MMP9	5.19e-07	5	131	3	27283026
Pubmed	Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization.	LPA PLAT PLAU	5.19e-07	5	131	3	12657615
Pubmed	The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection.	LPA PLAT PLAU	5.19e-07	5	131	3	12875972
Pubmed	The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent.	LPA PLAT PLAU	5.19e-07	5	131	3	11818362
Pubmed	Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.	LPA PLAT PLAU	5.19e-07	5	131	3	11306532
Pubmed	The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.	LPA PLAT PLAU	5.19e-07	5	131	3	10880388
Pubmed	Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure.	PLAT PLAU MMP9	1.04e-06	6	131	3	10502816
Pubmed	Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.	LPA PLAT PLAU	1.04e-06	6	131	3	10318667
Pubmed	Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation.	PLAT PLAU MMP9	1.04e-06	6	131	3	9398846
Pubmed	Insulin-like growth factor II receptor, transforming growth factor-beta, and Cdk4 expression and the developmental epigenetics of mouse palate morphogenesis and dysmorphogenesis.	LPA PLAT PLAU	2.88e-06	8	131	3	9438420
Pubmed	The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice.	LPA PLAT PLAU	2.88e-06	8	131	3	25893677
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	PEG10 DHX33 ZCCHC3 S100A8 NAT10 GPC4 USP7 NUP153 MOV10	7.52e-06	349	131	9	25665578
Pubmed	A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo.	LPA PLAT PLAU	8.43e-06	11	131	3	26647393
Pubmed	Altered gene expression and spongiotrophoblast differentiation in placenta from a mouse model of diabetes in pregnancy.	THSD4 SLC6A4 MMP9	8.43e-06	11	131	3	21491160
Pubmed	Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice.	PLAT PLAU	1.41e-05	2	131	2	10417613
Pubmed	Polyglutamylation is a post-translational modification with a broad range of substrates.	TTLL5 TTLL4	1.41e-05	2	131	2	18045879
Pubmed	The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.	PLAT PLAU	1.41e-05	2	131	2	16601837
Pubmed	Role of double knockdown of tPA and MMP-9 on regulating the left ventricular function and remodeling followed by transverse aortic constriction-induced hypertrophic cardiomyopathy in mice.	PLAT MMP9	1.41e-05	2	131	2	30323866
Pubmed	A homozygous deletion within the carbonic anhydrase-like domain of the Ptprg gene in murine L-cells.	PTPRG PLAU	1.41e-05	2	131	2	8453613
Pubmed	Identification of a carbonic anhydrase-like domain in the extracellular region of RPTP gamma defines a new subfamily of receptor tyrosine phosphatases.	PTPRG PLAU	1.41e-05	2	131	2	8382771
Pubmed	Ifit1 inhibits Japanese encephalitis virus replication through binding to 5' capped 2'-O unmethylated RNA.	IFIT1 IFIT1B	1.41e-05	2	131	2	23824812
Pubmed	A viral RNA structural element alters host recognition of nonself RNA.	IFIT1 IFIT1B	1.41e-05	2	131	2	24482115
Pubmed	Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9.	PLAU MMP9	1.41e-05	2	131	2	21075828
Pubmed	Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity.	PLAT PLAU	1.41e-05	2	131	2	11858492
Pubmed	IL-1beta stimulates urokinase-type plasminogen activator expression and secretion in human dental pulp cells.	PLAT PLAU	1.41e-05	2	131	2	18202522
Pubmed	The influence of opioid peptides on matrix metalloproteinase-9 and urokinase plasminogen activator expression in three cancer cell lines.	PLAU MMP9	1.41e-05	2	131	2	23350235
Pubmed	IFIT1 Differentially Interferes with Translation and Replication of Alphavirus Genomes and Promotes Induction of Type I Interferon.	IFIT1 IFIT1B	1.41e-05	2	131	2	25927359
Pubmed	IFIT1 Exerts Opposing Regulatory Effects on the Inflammatory and Interferon Gene Programs in LPS-Activated Human Macrophages.	IFIT1 IFIT1B	1.41e-05	2	131	2	30282041
Pubmed	Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator.	PLAT PLAU	1.41e-05	2	131	2	12356640
Pubmed	Regulation of plasminogen activators in human thyroid follicular cells and their relationship to differentiated function.	PLAT PLAU	1.41e-05	2	131	2	17458906
Pubmed	Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.	PLAT PLAU	1.41e-05	2	131	2	20856796
Pubmed	Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.	PLAT PLAU	1.41e-05	2	131	2	20445443
Pubmed	Chromosomal assignments of genes for tissue plasminogen activator and urokinase in mouse.	PLAT PLAU	1.41e-05	2	131	2	2821634
Pubmed	Ifit1 Protects Against Lipopolysaccharide and D-galactosamine-Induced Fatal Hepatitis by Inhibiting Activation of the JNK Pathway.	IFIT1 IFIT1B	1.41e-05	2	131	2	26459629
Pubmed	Genetic analysis of the plasminogen and coagulation system in mice.	PLAT PLAU	1.41e-05	2	131	2	8979118
Pubmed	Mouse Ifit1b is a cap1-RNA-binding protein that inhibits mouse coronavirus translation and is regulated by complexing with Ifit1c.	IFIT1 IFIT1B	1.41e-05	2	131	2	33454014
Pubmed	Suppression of argatroban-induced endogenous thrombolysis by PKSI-527, and antibodies to TPA and UPA, evaluated in a rat arterial thrombolysis model.	PLAT PLAU	1.41e-05	2	131	2	12719778
Pubmed	Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice.	PLAT PLAU	1.41e-05	2	131	2	9351457
Pubmed	Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.	PRSS3 SLC6A4	1.41e-05	2	131	2	18363639
Pubmed	Increased bone formation in mice lacking plasminogen activators.	PLAT PLAU	1.41e-05	2	131	2	12854826
Pubmed	The conserved Cockayne syndrome B-piggyBac fusion protein (CSB-PGBD3) affects DNA repair and induces both interferon-like and innate antiviral responses in CSB-null cells.	ERCC6 PGBD3	1.41e-05	2	131	2	22483866
Pubmed	Tissue plasminogen activator in the bed nucleus of stria terminalis regulates acoustic startle.	PLAT PLAU	1.41e-05	2	131	2	16125860
Pubmed	Identification and validation of Ifit1 as an important innate immune bottleneck.	IFIT1 IFIT1B	1.41e-05	2	131	2	22745654
Pubmed	Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.	PLAT PLAU	1.41e-05	2	131	2	7721771
Pubmed	Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo.	PLAT PLAU	1.41e-05	2	131	2	11238111
Pubmed	Plasminogen activators are involved in the degradation of bone by osteoclasts.	PLAT PLAU	1.41e-05	2	131	2	18691680
Pubmed	Plasminogen activators direct reorganization of the liver lobule after acute injury.	PLAT PLAU	1.41e-05	2	131	2	11238040
Pubmed	Gene-gene interactions between glutathione-s transferase M1 and matrix metalloproteinase 9 in the formation of hereditary predisposition to chronic obstructive pulmonary disease.	GSTM1 MMP9	1.41e-05	2	131	2	15085249
Pubmed	What role (if any) does the highly conserved CSB-PGBD3 fusion protein play in Cockayne syndrome?	ERCC6 PGBD3	1.41e-05	2	131	2	23369858
Pubmed	Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.	PLAU MMP9	1.41e-05	2	131	2	16880329
Pubmed	Isolation, characterization, and expression in Escherichia coli of two murine Mu class glutathione S-transferase cDNAs homologous to the rat subunits 3 (Yb1) and 4 (Yb2).	GSTM1 GSTM5	1.41e-05	2	131	2	2689439
Pubmed	Plasminogen activator expression correlates with genetic differences in vascular remodeling.	PLAT PLAU	1.41e-05	2	131	2	15528930
Pubmed	Secretions of MMP-9 by soluble glucocorticoid-induced tumor necrosis factor receptor (sGITR) mediated by protein kinase C (PKC)delta and phospholipase D (PLD) in murine macrophage.	PRKCD MMP9	1.41e-05	2	131	2	15156560
Pubmed	Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasion.	PLAU MMP9	1.41e-05	2	131	2	18355442
Pubmed	Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.	PLAT PLAU	1.41e-05	2	131	2	8647936
Pubmed	Contribution of postsynaptic T-type calcium channels to parallel fibre-Purkinje cell synaptic responses.	CACNA1I CACNA1G	1.41e-05	2	131	2	26627919
Pubmed	Overexpression of IFIT1 protects against LPS-induced acute lung injury via regulating CCL5-p65NF-κB signaling.	IFIT1 IFIT1B	1.41e-05	2	131	2	36446235
Pubmed	Pi-class glutathione-S-transferase-positive hepatocytes in aging B6C3F1 mice undergo apoptosis induced by dietary restriction.	GSTM1 GSTM5	1.41e-05	2	131	2	8909248
Pubmed	DNA methylation is associated with altered gene expression in AMD.	GSTM1 GSTM5	1.41e-05	2	131	2	22410570
Pubmed	Mutant Cockayne syndrome group B protein inhibits repair of DNA topoisomerase I-DNA covalent complex.	ERCC6 PGBD3	1.41e-05	2	131	2	21143350
Pubmed	The association between expression of IFIT1 in podocytes of MRL/lpr mice and the renal pathological changes it causes: An animal study.	IFIT1 IFIT1B	1.41e-05	2	131	2	27823966
Pubmed	Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression.	PLAU MMP9	1.41e-05	2	131	2	9079647
Pubmed	Characterization of the murine plasminogen/urokinase-type plasminogen-activator system.	PLAT PLAU	1.41e-05	2	131	2	8944773
Pubmed	Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis.	MMP9 NOS2	1.41e-05	2	131	2	17071581
Pubmed	Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA.	IFIT1 IFIT1B	1.41e-05	2	131	2	24098121
Pubmed	Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy.	PLAT MMP9	1.41e-05	2	131	2	12438450
Pubmed	Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator.	PLAT PLAU	1.41e-05	2	131	2	16127152
Pubmed	Role of inducible nitric oxide synthase in asthma risk and lung function growth during adolescence.	GSTM1 NOS2	1.41e-05	2	131	2	19996333
Pubmed	Human and Murine IFIT1 Proteins Do Not Restrict Infection of Negative-Sense RNA Viruses of the Orthomyxoviridae, Bunyaviridae, and Filoviridae Families.	IFIT1 IFIT1B	1.41e-05	2	131	2	26157117
Pubmed	Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury.	MMP9 NOS2	1.41e-05	2	131	2	19443702
Pubmed	An abundant evolutionarily conserved CSB-PiggyBac fusion protein expressed in Cockayne syndrome.	ERCC6 PGBD3	1.41e-05	2	131	2	18369450
Pubmed	Extracellular proteolysis of reelin by tissue plasminogen activator following synaptic potentiation.	RELN PLAT	1.41e-05	2	131	2	24892761
Pubmed	Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.	PLAT MMP9	1.41e-05	2	131	2	16051896
Pubmed	2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo.	IFIT1 IFIT1B	1.41e-05	2	131	2	22589727
Pubmed	Genomic organization and characterization of the promoter region of murine GSTM2 gene.	GSTM1 GSTM5	1.41e-05	2	131	2	11404019
Pubmed	Tissue-type plasminogen activator deficiency exacerbates arthritis.	PLAT PLAU	1.41e-05	2	131	2	11441114
Pubmed	Isolation of two human cDNAs, HLP3 and HLP4, homologous to the neuron-specific calcium-binding protein genes.	VSNL1 HPCAL4	1.41e-05	2	131	2	10520747
Pubmed	Sesamol regulates plasminogen activator gene expression in cultured endothelial cells: a potential effect on the fibrinolytic system.	PLAT PLAU	1.41e-05	2	131	2	15629242
Pubmed	Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.	PLAT PLAU	1.41e-05	2	131	2	11891190
Pubmed	Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.	PLAU MME	1.41e-05	2	131	2	15615772
Pubmed	Physiological consequences of loss of plasminogen activator gene function in mice.	PLAT PLAU	1.41e-05	2	131	2	8133887
Pubmed	Mice deficient in urokinase-type plasminogen activator have delayed healing of tympanic membrane perforations.	PLAT PLAU	1.41e-05	2	131	2	23236466
Pubmed	Evolution-guided functional analyses reveal diverse antiviral specificities encoded by IFIT1 genes in mammals.	IFIT1 IFIT1B	1.41e-05	2	131	2	27240734
Pubmed	Cerebrospinal fluid u-plasminogen activator and matrix metalloproteinase-9 levels in human eosinophilic meningitis associated with angiostrongyliasis.	PLAU MMP9	1.41e-05	2	131	2	20584616
Pubmed	Progesterone regulation of glutathione S-transferase Mu2 expression in mouse uterine luminal epithelium during preimplantation period.	GSTM1 GSTM5	1.41e-05	2	131	2	18692819
Pubmed	GSTM1 and GSTM5 Genetic Polymorphisms and Expression in Age-Related Macular Degeneration.	GSTM1 GSTM5	1.41e-05	2	131	2	25897651
Pubmed	Protein kinase Cdelta and protein tyrosine kinase regulate peptidoglycan-induced nuclear factor-kappaB activation and inducible nitric oxide synthase expression in mouse peritoneal macrophages in vitro.	PRKCD NOS2	1.41e-05	2	131	2	19931912
Pubmed	Hypoxia enhances gene expression of inducible nitric oxide synthase and matrix metalloproteinase-9 in ras/myc-transformed serum-free mouse embryo cells under simulated inflammatory and infectious conditions.	MMP9 NOS2	1.41e-05	2	131	2	18474440
Cytoband	10p12.33	MRC1 ST8SIA6	2.24e-04	8	131	2	10p12.33
GeneFamily	Fibronectin type III domain containing	OBSCN TYRO3 PTPRG PTPRZ1 FNDC8 EPHA5	1.57e-04	160	91	6	555
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND4B DENND2C DENND5A	2.62e-04	25	91	3	504
GeneFamily	Calcium voltage-gated channel subunits	CACNA1I CACNA1G CACNA2D3	2.95e-04	26	91	3	253
GeneFamily	Tubulin tyrosine ligase family	TTLL5 TTLL4	2.19e-03	14	91	2	779
GeneFamily	ATP binding cassette subfamily A	ABCA3 ABCA10	2.19e-03	14	91	2	805
GeneFamily	DEAH-box helicases	DHX33 DHX29	2.87e-03	16	91	2	500
GeneFamily	Dyneins, axonemal	DNAH12 DNAH6	3.24e-03	17	91	2	536
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS10 ADAMTS14	4.05e-03	19	91	2	50
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRG PTPRZ1	4.94e-03	21	91	2	813
Coexpression	GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN	CA12 ABCA3 IFIT1 CEMIP PTPRZ1 DNAI4 DENND5A TNS3	5.53e-06	194	129	8	M8864
Coexpression	NABA_MATRISOME	THSD4 PRSS3 RELN TSPEAR ADAMTS10 S100A8 TGM3 PRG3 LPA SLIT3 GPC4 PLAT PLAU CLEC3B ADAMTS14 MMP9 FNDC8	9.51e-06	1008	129	17	MM17056
Coexpression	KRAS.600_UP.V1_UP	DOCK4 RELN MTMR8 PRG3 PLAT PLAU MMP9 FNDC8 KCNAB3	1.04e-05	279	129	9	M2882
Coexpression	NABA_MATRISOME	THSD4 PRSS3 RELN TSPEAR ADAMTS10 S100A8 TGM3 PRG3 LPA SLIT3 GPC4 PLAT PLAU CLEC3B ADAMTS14 MMP9 FNDC8	1.20e-05	1026	129	17	M5889
Coexpression	NABA_ECM_REGULATORS	PRSS3 ADAMTS10 TGM3 LPA PLAT PLAU ADAMTS14 MMP9	2.44e-05	238	129	8	M3468
Coexpression	NABA_ECM_REGULATORS	PRSS3 ADAMTS10 TGM3 LPA PLAT PLAU ADAMTS14 MMP9	2.74e-05	242	129	8	MM17062
Coexpression	BOQUEST_STEM_CELL_UP	PEG10 GAS7 GSTM5 PTPRG AGL SLIT3 GPC4 MME	4.69e-05	261	129	8	M1834
Coexpression	GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN	CA12 PSMA3 S100A8 GPC4 RRH DENND5A MMP9	5.99e-05	199	129	7	M5230
Coexpression	BURTON_ADIPOGENESIS_9	GALK2 GSTM1 GPC4 PRKCD PLAT	6.39e-05	85	129	5	M1666
Coexpression	KRAS.600.LUNG.BREAST_UP.V1_UP	DOCK4 PRSS3 RELN MTMR8 PRG3 MMP9 FNDC8 KCNAB3	7.67e-05	280	129	8	M2886
Coexpression	BURTON_ADIPOGENESIS_9	GALK2 GSTM1 GPC4 PRKCD PLAT	7.96e-05	89	129	5	MM1026
Coexpression	GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN	ACADVL POLD1 GAS7 S100A8 EHHADH LPA CLEC3B CACNA2D3	9.10e-05	287	129	8	M40958
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RELN TNFAIP8L3 ZAN PEG10 PTPRZ1 GPC4 GRIN3A	3.44e-07	152	131	7	8ff5a178a8f3550d89a003c0858820aab3773386
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 ARSI ST8SIA6 TECPR2 GPC4 PLAU CACNA1G	4.86e-07	160	131	7	56e6f4b82b5dc41c45f9d253c2db314a6f702b84
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 ARSI ST8SIA6 TECPR2 GPC4 PLAU CACNA1G	4.86e-07	160	131	7	bb1b966fb9e801db15e67d03e49db4609d6f935a
ToppCell	BAL-Severe-Myeloid-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ERV3-1 IFIT1 S100A8 TGM3 TECPR2 PLAU MMP9	8.22e-07	173	131	7	5b76d9cc56bbb29017e64a2d0a3c76c0be003d96
ToppCell	BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ERV3-1 IFIT1 S100A8 TGM3 TECPR2 PLAU MMP9	8.22e-07	173	131	7	bf685025961e79b379f2c35464b6c8ce3e31ace0
ToppCell	BAL-Severe-Myeloid-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ERV3-1 IFIT1 S100A8 TGM3 TECPR2 PLAU MMP9	8.22e-07	173	131	7	a6e73a40b0d5356564a594053e772f9d061a5919
ToppCell	BAL-Severe-Myeloid-Neutrophil-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ERV3-1 IFIT1 S100A8 TGM3 TECPR2 PLAU MMP9	8.22e-07	173	131	7	a8b5370f4c893a20c58e97659f3ac168699693f8
ToppCell	BAL-Severe-Myeloid-Neutrophil-Neutrophil-Neu_3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ERV3-1 IFIT1 S100A8 TGM3 TECPR2 PLAU MMP9	8.22e-07	173	131	7	1edef5aeab626cbf2c09468e77b02cfa2d21ba03
ToppCell	BAL-Severe-Myeloid-Neutrophil-Neutrophil\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ERV3-1 IFIT1 S100A8 TGM3 TECPR2 PLAU MMP9	8.22e-07	173	131	7	c37dba3804df7c3151e18e6ae4e0b6e7a92bae97
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK3 MRC1 RELN TRIM62 PLAU ZSCAN2 CACNA2D3	8.88e-07	175	131	7	0801cccec6915aefc135262fc74580280fd51aa5
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOCK3 MRC1 RELN TRIM62 PLAU ZSCAN2 CACNA2D3	8.88e-07	175	131	7	09163e7030f76d706eccabdb1d5ec45f8412aa75
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	THSD4 PRSS3 RELN STAP2 ST8SIA6 DNAH6 HPCAL4	9.23e-07	176	131	7	460cb302c5b3d609c65b924e1d4e8ea057a68485
ToppCell	Severe_COVID-19-Myeloid-Neutrophil\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	ERV3-1 IFIT1 S100A8 TGM3 TECPR2 PLAU MMP9	9.59e-07	177	131	7	a6fae376f1beb1df423484d9b1bd1d954ca117af
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CA12 PRSS3 VSNL1 CEMIP S100A8 PTPRZ1 PLAT	1.20e-06	183	131	7	bbf27d2f4369031fadacacd6c432c06b1ec5abdb
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TNFAIP8L3 ST8SIA6 GRIN3A ALK PALLD TNS3	1.38e-06	187	131	7	d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 DOCK3 TTLL5 USP24 IFIT1 TTLL4 PALLD	1.43e-06	188	131	7	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 DOCK3 TTLL5 USP24 IFIT1 TTLL4 PALLD	1.43e-06	188	131	7	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 DOCK3 TTLL5 USP24 IFIT1 TTLL4 PALLD	1.43e-06	188	131	7	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN TNFAIP8L3 ST8SIA6 PTPRZ1 GRIN3A ALK TNS3	1.43e-06	188	131	7	ee572246e0c2f41bdbc29a03edc67b831af95c09
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RELN TYRO3 SLIT3 GPC4 WSCD2 MME PALLD	1.77e-06	194	131	7	1374600957c7d7f0b05fd2c1186f521b9096d4ef
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DOCK4 GAS7 ABCA10 SLIT3 MME SH3RF3 PALLD	2.16e-06	200	131	7	e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	THSD4 FBXW12 POLD1 USP24 RDH12 PLAU SH3RF3	2.16e-06	200	131	7	b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Cdh13\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	COLGALT2 TGM3 SLIT3 GPC4 LRATD2 MMP9	3.13e-06	136	131	6	1f3000d5f105c87c80f8ae1dd2264bcd7f757a9c
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RELN TGM3 SLIT3 GPC4 LRATD2 MMP9	3.70e-06	140	131	6	7cc891d676555609add6fc7880735d948a2ad801
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RELN TNFAIP8L3 ZAN PEG10 PTPRZ1 GRIN3A	5.10e-06	148	131	6	5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RELN RAPSN IFIT1 GSTM1 GRIN3A ALK	6.41e-06	154	131	6	a2adaa4a6cd8708cd579b8efbeb4ff2131c5482e
ToppCell	COVID-CD4-antiviral_CD4\|COVID / Condition, Cell_class and T cell subcluster	MTMR8 COLGALT2 IFIT1 NAT10 CACNA1I DNAH6	6.65e-06	155	131	6	7e5ae034036fe85915d38a24195501e6d3bcbfb0
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4\|GI_large-bowel / Manually curated celltypes from each tissue	INPP5A NAT10 LRATD2 MMP9 NUDT15 HPCAL4	6.90e-06	156	131	6	01f2c0c6a936dfb59bc727feef428a906ad2a80b
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	GSTM1 TYRO3 LINC02902 GYS1 PRKCD TNS3	7.16e-06	157	131	6	2c1219ee19a6246a3b9f5c2c1a37f26ea934a822
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MRC1 ARSI LDHD ST8SIA6 GPC4 CACNA1G	8.26e-06	161	131	6	60f433eab9d5531bdf6aa86b0265f20b866b904c
ToppCell	E12.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MRC1 RELN STAP2 PLAU MMP9 FNDC8	8.87e-06	163	131	6	c21114826bee1b05b411984326fef6b6e0d05316
ToppCell	E12.5-Endothelial-lymphatic_endothelial_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MRC1 RELN STAP2 PLAU MMP9 FNDC8	8.87e-06	163	131	6	5d49414432db259a19df50d7944581d00b69f537
ToppCell	facs-Trachea-nan-18m-Myeloid-granulocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERV3-1 SLC6A4 S100A8 MMP9 FNDC8 KCNAB3	9.84e-06	166	131	6	7f8b4cf63c3e292ae421f111edaa4572717f4db1
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	THSD4 ZNF492 RELN DHX33 IFIT1 WSCD2	1.24e-05	173	131	6	b43817a6b1ed8d6b5366702343be4311c0d52d83
ToppCell	facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSTM1 LDHD EHHADH GPC4 CNDP2 MME	1.33e-05	175	131	6	076ad81d6cbeea5512393d192af3ab5aa1f82975
ToppCell	facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSTM1 LDHD EHHADH GPC4 CNDP2 MME	1.33e-05	175	131	6	445ccb9744a3a9ff37164c532afbe769d306b6c8
ToppCell	5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RELN TNFAIP8L3 TSPEAR STAP2 CEMIP NOS2	1.42e-05	177	131	6	76f5df101c693e5fa61554244d877fc8169ee66f
ToppCell	10x5'v1-week_14-16-Myeloid_macrophage-stroma-osteoclast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	SPR STAP2 DCSTAMP ADAMTS14 MMP9 PALLD	1.46e-05	178	131	6	a28683690ab8a60eb18f3ef87ea85da4e95b22df
ToppCell	Severe-Myeloid-Neutrophil\|Severe / Condition, Lineage, Cell class and cell subclass	ERV3-1 IFIT1 S100A8 TGM3 TECPR2 PLAU	1.46e-05	178	131	6	454313efe59d71e7327b9758efabf2d893e4a8fd
ToppCell	Severe-Myeloid-Neutrophil-\|Severe / Condition, Lineage, Cell class and cell subclass	ERV3-1 IFIT1 S100A8 TGM3 TECPR2 PLAU	1.46e-05	178	131	6	8618ae891d62bf70fe860ff7bb2d31868961aa13
ToppCell	droplet-Limb_Muscle-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HEXB GSTM1 S100A8 CNDP2 PLAT CLEC3B	1.51e-05	179	131	6	013818e173101efca7625ccd4258e60655815d73
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DOCK3 COLGALT2 PTPRG SH3RF3 ALK CACNA2D3	1.51e-05	179	131	6	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 INPP5A ADGRL1 ZSCAN2 CACNA1G PALLD	1.56e-05	180	131	6	a37cc885fe3f6cb9df69d43358064c83c18412e7
ToppCell	facs-Heart-RV-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	THSD4 INPP5A ADGRL1 ZSCAN2 CACNA1G PALLD	1.56e-05	180	131	6	63a6d532b16b8b15c7c9102148d7297ee3afd641
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CA12 INPP5A TTLL5 MFSD6 TTLL4 KCNAB3	1.56e-05	180	131	6	be10fe5bf7c3a671c42704ce7dd8226ab6896794
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CA12 INPP5A TTLL5 MFSD6 TTLL4 KCNAB3	1.56e-05	180	131	6	3b747a517ce75ef2ff09011c037dad7b01ed3e03
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-medium_spiny_neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CA12 SLIT3 WSCD2 MME HPCAL4 CACNA2D3	1.66e-05	182	131	6	d41ff834b8fc1d0e23cac7ae261de5f72874e462
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal-SPN_Neuron_STR\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CA12 SLIT3 WSCD2 MME HPCAL4 CACNA2D3	1.66e-05	182	131	6	6cde859edfe7607bd7ada89d20258413d06f4207
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	THSD4 DOCK3 VSNL1 ADAMTS10 SLIT3 PALLD	1.71e-05	183	131	6	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	Mild_COVID-19-Myeloid-MoAM4\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	GAS7 TTLL4 PLAU CACNA1G MMP9 TNS3	1.76e-05	184	131	6	63ef6ba6ac33c3032735008ce3b411636ab3c395
ToppCell	droplet-Marrow-nan-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HEXB STAP2 GSTM1 S100A8 TBRG1 GYS1	1.82e-05	185	131	6	3dcafbd02b65a2befbb6e6288cb2591e721cddb6
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CA12 VSNL1 STAP2 PTPRZ1 AGL PLAT	1.82e-05	185	131	6	e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSTM1 SLIT3 PLAT CLEC3B SH3RF3 CACNA2D3	1.88e-05	186	131	6	cc94e0c5d1665d2ea2bb871ad79d8e1ec2249fb5
ToppCell	10x5'v1-week_12-13-Myeloid_macrophage-stroma-osteoclast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SPR STAP2 DCSTAMP ADAMTS14 MMP9 PALLD	1.88e-05	186	131	6	c9dfcf7bba7e5ef97ad5d9b7084fba932c91ab68
ToppCell	10x5'v1-week_17-19-Myeloid_macrophage-stroma-osteoclast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SPR STAP2 DCSTAMP ADAMTS14 MMP9 PALLD	1.99e-05	188	131	6	762b52f21d2bc5409f86746a904c4358490be9c0
ToppCell	droplet-Limb_Muscle-nan-24m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GSTM1 SLIT3 CNDP2 PLAT PLAU CLEC3B	2.05e-05	189	131	6	6e52cac679e0541ca5f2be316bdabdbc34da6e18
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	THSD4 MRC1 SIN3B RELN TNFAIP8L3 TSPEAR	2.11e-05	190	131	6	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	10x5'v1-week_12-13-Myeloid_macrophage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SPR STAP2 DCSTAMP ADAMTS14 MMP9 PALLD	2.18e-05	191	131	6	be2fe2583bdcee0b35c43a347da9c4adb93e30e0
ToppCell	10x5'v1-week_12-13-Myeloid_macrophage-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SPR STAP2 DCSTAMP ADAMTS14 MMP9 PALLD	2.18e-05	191	131	6	4cebaf31d4f09f4ab273a819ad5cbff7d9a9b341
ToppCell	facs-Skin-Anagen-3m-Epithelial-basal_cell_of_epidermis\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CA12 SLC6A4 TGM3 IL22RA2 PTPRZ1 ADAMTS14	2.24e-05	192	131	6	ec1fd2fb6e71f87189d66261909a84e2be63cacb
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DOCK4 PTPRG ST8SIA6 PLAT TMEM184B	2.24e-05	192	131	6	3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CA12 S100A8 PLAT PLAU NOS2 PALLD	2.31e-05	193	131	6	463274f394757fb2570ae885d58e1f9fa7e60c4a
ToppCell	Bronchial_Biopsy-Immune-Luminal_Macrophages\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	HEXB MRC1 DCSTAMP S100A8 MME TNS3	2.45e-05	195	131	6	6800c17026ec6c56132bf4664b8fcd74d7836579
ToppCell	PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	VSNL1 S100A8 TGM3 MME MMP9	2.50e-05	117	131	5	089793a950e8593b4acc1ba6a5e5474682f5fda6
ToppCell	PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_1\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	VSNL1 S100A8 TGM3 MME MMP9	2.50e-05	117	131	5	3d98d77b4725d684e7496059e8b0ffffbe40301d
ToppCell	PND01-03-samps-Mesenchymal-Matrix_fibroblast\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DOCK4 GAS7 CLEC3B MME PALLD TNS3	2.52e-05	196	131	6	54f4cf778f95a9ff662e5c7520916a25e605bf95
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DOCK4 RELN PTPRG ST8SIA6 PLAT	2.52e-05	196	131	6	8f2031b1a9232c389517fbf3c29f47f9468b0077
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DOCK4 RELN PTPRG ST8SIA6 PLAT	2.52e-05	196	131	6	48b4a9cea97a55190217deaf51bf867608c5a9a7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 DOCK4 RELN PTPRG ST8SIA6 PLAT	2.52e-05	196	131	6	473980c827443464d08a0be28c53e3536369b12a
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RELN TYRO3 SLIT3 GPC4 WSCD2 PALLD	2.52e-05	196	131	6	545d2e4469924d333e3f655f559c899fa1260196
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRSS3 VSNL1 S100A8 PTPRZ1 DENND2C PLAT	2.59e-05	197	131	6	fb272c9c60ee3d980e528044dc567b4925a23da6
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ECT2L DNAH12 DNAI4 C11orf97 DNAH6 PALLD	2.59e-05	197	131	6	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ECT2L DNAH12 DNAI4 C11orf97 DNAH6 PALLD	2.59e-05	197	131	6	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	COVID-19-kidney-Macrophages\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DOCK4 MRC1 DCSTAMP S100A8 MMP9 TNS3	2.59e-05	197	131	6	3912301018d0863144dcfac8d1fa8adc081748d7
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 ABCA10 CEMIP SLIT3 SH3RF3 PALLD	2.59e-05	197	131	6	ae0435f4b4a9cdedb1c201fc56921048390097bf
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	THSD4 ABCA10 CEMIP SLIT3 SH3RF3 PALLD	2.59e-05	197	131	6	37f6b6f2809b952382eaebb642b0aad6371f4251
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ECT2L DNAH12 DNAI4 C11orf97 DNAH6 PALLD	2.59e-05	197	131	6	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRSS3 VSNL1 S100A8 PTPRZ1 DENND2C PLAT	2.59e-05	197	131	6	61c0d78b29dc4ad8a84172cbfcdab03f31351d0e
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ECT2L DNAH12 DNAI4 C11orf97 DNAH6 PALLD	2.59e-05	197	131	6	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CA12 VSNL1 CEMIP S100A8 DENND2C PLAU	2.59e-05	197	131	6	2430f31d9312338e0ca23bfc6bdb0365340860fd
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CA12 VSNL1 CEMIP PTPRZ1 DENND2C PLAT	2.74e-05	199	131	6	c88a28a73f54dc571f2ff1e4b55073f83cbead2c
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CA12 STAP2 S100A8 PTPRZ1 AGL PLAT	2.74e-05	199	131	6	ba284f984909504221900bca5ea12ada5b2ffd9f
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN ST8SIA6 PTPRZ1 GRIN3A ALK TNS3	2.82e-05	200	131	6	c74bc12e13d002dedaaf75a2244ec111e47524e1
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	RELN ST8SIA6 PTPRZ1 GRIN3A ALK TNS3	2.82e-05	200	131	6	ead9eb579bb25fde05fc15602e3d05ab6617f7ac
ToppCell	wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	PEG10 ABCA10 ARSI GSTM5 PLAT PALLD	2.82e-05	200	131	6	d769723f8fcb37d9b86589e0c41c1d7f16393cfe
ToppCell	Caecum-Macrophage-Macrophage\|Caecum / Region, Cell class and subclass	DOCK4 MRC1 GAS7 S100A8 PLAU CACNA2D3	2.82e-05	200	131	6	99dcf07b17ecf90d596f3b8a12d5b7aae2a351d5
ToppCell	Caecum-(6)_Macrophage-(60)_Macrophage\|Caecum / shred on region, Cell_type, and subtype	DOCK4 MRC1 GAS7 S100A8 PLAU CACNA2D3	2.82e-05	200	131	6	67b6cdeb07ffc5c9af7a3e738dd31256cf391e98
ToppCell	Caecum-(6)_Macrophage\|Caecum / shred on region, Cell_type, and subtype	DOCK4 MRC1 GAS7 S100A8 PLAU CACNA2D3	2.82e-05	200	131	6	2ce3930645c3daf6be578f7881e57a58df61e75c
ToppCell	Caecum-Macrophage\|Caecum / Region, Cell class and subclass	DOCK4 MRC1 GAS7 S100A8 PLAU CACNA2D3	2.82e-05	200	131	6	d83209559187a4419df2508ecc5eb9f7d72fced3
ToppCell	wk_15-18-Mesenchymal-Fibroblast-intermediate_fibro\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PEG10 ABCA10 ARSI GSTM5 PLAT PALLD	2.82e-05	200	131	6	6461d25fd8fb52921b188f083fbe808535d3130b
ToppCell	droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPSF4L IFIT1 PTPRG ST8SIA6 DNAH6	3.44e-05	125	131	5	35042ed43045dddc341b76cc5f9fe31b5ba0abb8
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	S100A8 CASD1 AGL MMP9 DHX29	4.62e-05	133	131	5	f6e9a1301a3379847b215303a9b0c028841e2cc0
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	S100A8 CASD1 AGL MMP9 DHX29	4.62e-05	133	131	5	292ecfcadbaf15e0d34a3ab9bf511ab1065888bd
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tfh\|GI_small-bowel / Manually curated celltypes from each tissue	MTMR8 IFIT1 DNAH12 DNAI4 CACNA1I	4.79e-05	134	131	5	bf94ce5edde8912a27010e229c313d8102d6de62
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RELN IFIT1 GSTM1 GRIN3A ALK	5.14e-05	136	131	5	e3a2425ba5ef538dbacab1479e682837ae42a888
ToppCell	Control-Epithelial_alveolar-AT_1-Differentiating_AT2\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	RELN IL17RE DENND2C MME NUDT15	5.51e-05	138	131	5	611fe0fb284e12678f9c47a0bdbfc367a93c52b3
ToppCell	PBMC-Severe-Myeloid-Neutrophil-Neutrophil-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PRSS3 IFIT1 S100A8 MME MMP9	5.70e-05	139	131	5	fa0eedebf53317928022c3bed391ce99a2114f98
ToppCell	Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Cacng4_(Non-anterior_nuclei)\|Thalamus / BrainAtlas - Mouse McCarroll V32	TSPEAR ARSI IL17RE PRKCD	7.49e-05	76	131	4	4afc8d0e79870c635a89dd8e7ca91ebfe482b4ab
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA10 CEMIP ADAMTS10 SH3RF3 PALLD	8.18e-05	150	131	5	1270f33f9d7e46e55adf1a96e8beee858b95589d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA10 CEMIP ADAMTS10 SH3RF3 PALLD	8.18e-05	150	131	5	156118ce1d69522624196410cba18b8354cd0bb4
Drug	dermatan sulfate	HEXB MRC1 PRSS3 ERCC6 ARSI PRG3 PTPRZ1 GPC4 MMP9 PGBD3	5.22e-07	220	129	10	CID000032756
Drug	hyaluronan	HEXB PRSS3 ERCC6 PRG3 PTPRZ1 GPC4 PLAT PLAU MMP9 PGBD3	2.63e-06	263	129	10	CID000024759
Drug	guanosine 3',5'-cyclic monophosphoric acid	VSNL1 TNFAIP8L3 PEG10 RNF17 PHKG2 RRH PRKCD CACNA1I PLAU CACNA1G MME MMP9 NOS2 CACNA2D3	5.19e-06	577	129	14	CID000000295
Drug	ethanol	CA12 PRSS3 TNFAIP8L3 POLD1 PEG10 GSTM1 SLC6A4 GSTM5 LDHD GYS1 PRKCD PLAT CACNA1I PLAU CLEC3B GRIN3A NOS2	5.21e-06	837	129	17	CID000000702
Drug	Vinblastine	ABCA3 GAS7 S100A8 PRKCD PLAT PLAU TMEM97 MME NUDT15	1.84e-05	261	129	9	ctd:D014747
Drug	TAPAP	PRSS3 PLAT PLAU	2.07e-05	10	129	3	CID000126363
Drug	bis(4-hydroxycinnamoyl)methane	PRKCD PLAU MMP9 NOS2	2.40e-05	30	129	4	ctd:C034786
Drug	Lovastatin	ERCC6 PSMA3 XIAP LPA PRKCD PLAT MMP9 NOS2	2.78e-05	211	129	8	ctd:D008148
Drug	tranexamic acid	LPA PLAT PLAU CLEC3B NOS2	3.15e-05	64	129	5	CID000005526
Drug	perhydrodiazepine	SLC6A4 NOS2	3.19e-05	2	129	2	CID012680363
Drug	xylosides	PLAU MMP9	3.19e-05	2	129	2	ctd:C010807
Drug	azotochelin	ERCC6 PGBD3	3.19e-05	2	129	2	CID000193592
Disease	Vasogenic Brain Edema	PLAU MMP9 NOS2	3.80e-06	8	122	3	C0750969
Disease	Cytotoxic Brain Edema	PLAU MMP9 NOS2	3.80e-06	8	122	3	C0750970
Disease	Cytotoxic Cerebral Edema	PLAU MMP9 NOS2	3.80e-06	8	122	3	C0472388
Disease	Vasogenic Cerebral Edema	PLAU MMP9 NOS2	3.80e-06	8	122	3	C0472387
Disease	Brain Edema	PLAU MMP9 NOS2	3.80e-06	8	122	3	C1527311
Disease	Cerebral Edema	PLAU MMP9 NOS2	3.80e-06	8	122	3	C0006114
Disease	Glycogen Storage Disease	PHKG2 AGL GYS1 SLC37A4	4.53e-06	27	122	4	C0017919
Disease	Thromboembolism	LPA PLAT PLAU	1.48e-05	12	122	3	C0040038
Disease	Amphetamine-Related Disorders	DCSTAMP GSTM1 SLC6A4 PLAT SH3RF3	1.52e-05	75	122	5	C0236733
Disease	Amphetamine Abuse	DCSTAMP GSTM1 SLC6A4 PLAT SH3RF3	1.52e-05	75	122	5	C0236807
Disease	Amphetamine Addiction	DCSTAMP GSTM1 SLC6A4 PLAT SH3RF3	1.52e-05	75	122	5	C0236804
Disease	Intracranial Embolism and Thrombosis	PLAT PLAU	1.70e-05	2	122	2	C0007781
Disease	Cerebral Embolism and Thrombosis	PLAT PLAU	1.70e-05	2	122	2	C0877855
Disease	Brain Embolism and Thrombosis	PLAT PLAU	1.70e-05	2	122	2	C0936247
Disease	Cholesterol Embolism	PLAT PLAU	1.70e-05	2	122	2	C0149649
Disease	brain edema (biomarker_via_orthology)	PLAT PLAU MMP9	3.03e-05	15	122	3	DOID:4724 (biomarker_via_orthology)
Disease	middle cerebral artery infarction (biomarker_via_orthology)	ERCC6 PTPRZ1 PLAT MMP9 NOS2	4.32e-05	93	122	5	DOID:3525 (biomarker_via_orthology)
Disease	Glycogen storage disease	PHKG2 AGL SLC37A4	4.49e-05	17	122	3	cv:C0017919
Disease	bacteriemia	DOCK3 PTPRG PALLD	4.49e-05	17	122	3	EFO_0003033
Disease	Arterial Occlusive Diseases	PLAT PLAU	5.07e-05	3	122	2	C0003838
Disease	Acute Cerebrovascular Accidents	LPA PLAT PLAU NOS2	7.50e-05	54	122	4	C0751956
Disease	free cholesterol to total lipids in large HDL percentage	RAPSN GSTM1 LPA MMP9	8.65e-05	56	122	4	EFO_0022279
Disease	gestational age, birth measurement	RAPSN INPP5A CACNA2D3	8.69e-05	21	122	3	EFO_0005112, EFO_0006921
Disease	Deep Vein Thrombosis	LPA PLAT PLAU	8.69e-05	21	122	3	C0149871
Disease	Venous Thrombosis	LPA PLAT PLAU	8.69e-05	21	122	3	C0042487
Disease	saturated fatty acids to total fatty acids percentage	RAPSN GSTM1 LPA	8.69e-05	21	122	3	EFO_0022305
Disease	Atherosclerosis	GSTM1 LPA PLAT NOS2	1.06e-04	59	122	4	C0004153
Disease	Atherogenesis	GSTM1 LPA PLAT NOS2	1.06e-04	59	122	4	C1563937
Disease	Brain Ischemia	PLAT PLAU MMP9 NOS2	1.13e-04	60	122	4	C0007786
Disease	Cerebral Ischemia	PLAT PLAU MMP9 NOS2	1.13e-04	60	122	4	C0917798
Disease	Cerebrovascular accident	LPA PLAT PLAU NOS2	1.29e-04	62	122	4	C0038454
Disease	colon adenocarcinoma (is_marker_for)	CA12 MMP9 NOS2	1.48e-04	25	122	3	DOID:234 (is_marker_for)
Disease	macular degeneration (is_marker_for)	ERCC6 GSTM1 MMP9	1.67e-04	26	122	3	DOID:4448 (is_marker_for)
Disease	Posterior Fossa Hemorrhage	PLAT PLAU	1.68e-04	5	122	2	C0751893
Disease	renal hypertension (implicated_via_orthology)	MMP9 NOS2	1.68e-04	5	122	2	DOID:1073 (implicated_via_orthology)
Disease	peritonitis (is_implicated_in)	PLAT PLAU	1.68e-04	5	122	2	DOID:8283 (is_implicated_in)
Disease	Brugada syndrome (implicated_via_orthology)	GSTM1 GSTM5	1.68e-04	5	122	2	DOID:0050451 (implicated_via_orthology)
Disease	Intracranial Hemorrhage	PLAT PLAU	1.68e-04	5	122	2	C0151699
Disease	Cerebral Hemorrhage	PLAT PLAU MMP9	2.09e-04	28	122	3	C2937358
Disease	larynx cancer (is_implicated_in)	ERCC6 GSTM1	2.52e-04	6	122	2	DOID:2596 (is_implicated_in)
Disease	pulmonary emphysema (biomarker_via_orthology)	MMP9 NOS2	2.52e-04	6	122	2	DOID:9675 (biomarker_via_orthology)
Disease	pulmonary hypertension (is_implicated_in)	SLC6A4 MMP9 NOS2	2.58e-04	30	122	3	DOID:6432 (is_implicated_in)
Disease	Schizophrenia	DOCK4 RELN VSNL1 INPP5A GSTM1 SLC6A4 PTPRZ1 SLIT3 PLAT GRIN3A MMP9 ALK	3.06e-04	883	122	12	C0036341
Disease	Asthma	GSTM1 PLAU MMP9 NOS2	3.45e-04	80	122	4	C0004096
Disease	angle-closure glaucoma (is_implicated_in)	GSTM1 MMP9	3.51e-04	7	122	2	DOID:13550 (is_implicated_in)
Disease	Middle Cerebral Artery Embolus	PLAT PLAU MMP9	3.76e-04	34	122	3	C0751845
Disease	Embolic Infarction, Middle Cerebral Artery	PLAT PLAU MMP9	3.76e-04	34	122	3	C0751847
Disease	Left Middle Cerebral Artery Infarction	PLAT PLAU MMP9	3.76e-04	34	122	3	C0751846
Disease	Right Middle Cerebral Artery Infarction	PLAT PLAU MMP9	3.76e-04	34	122	3	C0751849
Disease	Thrombotic Infarction, Middle Cerebral Artery	PLAT PLAU MMP9	3.76e-04	34	122	3	C0751848
Disease	Middle Cerebral Artery Occlusion	PLAT PLAU MMP9	3.76e-04	34	122	3	C0740391
Disease	Infarction, Middle Cerebral Artery	PLAT PLAU MMP9	3.76e-04	34	122	3	C0740392
Disease	Middle Cerebral Artery Thrombosis	PLAT PLAU MMP9	3.76e-04	34	122	3	C0740376
Disease	Middle Cerebral Artery Syndrome	PLAT PLAU MMP9	3.76e-04	34	122	3	C0238281
Disease	Bone neoplasms	PLAU MMP9	4.67e-04	8	122	2	C0005967
Disease	response to statin, low density lipoprotein cholesterol measurement	CEMIP LPA	4.67e-04	8	122	2	EFO_0004611, GO_0036273
Disease	Malignant Bone Neoplasm	PLAU MMP9	4.67e-04	8	122	2	C0279530
Disease	Reperfusion Injury	PLAT PLAU MMP9 NOS2	5.18e-04	89	122	4	C0035126
Disease	sleep duration, low density lipoprotein cholesterol measurement	RAPSN USP24 SLC6A4 LPA	5.63e-04	91	122	4	EFO_0004611, EFO_0005271
Disease	Marfan Syndrome, Type I	MMP9 NOS2	5.99e-04	9	122	2	C4721845
Disease	Myocardial Infarction	PLAT PLAU MMP9 NOS2	6.62e-04	95	122	4	C0027051
Disease	autistic disorder (is_implicated_in)	RELN GSTM1 SLC6A4	7.04e-04	42	122	3	DOID:12849 (is_implicated_in)
Disease	chronic obstructive pulmonary disease (is_marker_for)	GSTM1 PLAU MMP9 NOS2	7.16e-04	97	122	4	DOID:3083 (is_marker_for)
Disease	Alzheimer's disease (is_marker_for)	RELN ACADVL LPA PLAU MMP9 NOS2	7.17e-04	257	122	6	DOID:10652 (is_marker_for)
Disease	Brain hemorrhage	PLAT PLAU	7.47e-04	10	122	2	C0553692
Disease	osteonecrosis (is_implicated_in)	GSTM1 PLAT	7.47e-04	10	122	2	DOID:10159 (is_implicated_in)
Disease	liver cirrhosis (is_implicated_in)	GSTM1 SLC6A4 PHKG2	7.54e-04	43	122	3	DOID:5082 (is_implicated_in)
Disease	myocardial infarction (is_implicated_in)	LPA PLAT PLAU MMP9	7.73e-04	99	122	4	DOID:5844 (is_implicated_in)
Disease	sciatic neuropathy (biomarker_via_orthology)	PLAT CACNA1I PLAU MMP9	7.73e-04	99	122	4	DOID:11446 (biomarker_via_orthology)
Disease	status epilepticus (biomarker_via_orthology)	RELN PTPRZ1 PLAU MMP9	8.03e-04	100	122	4	DOID:1824 (biomarker_via_orthology)
Disease	Posterior Choroidal Artery Infarction	PLAT PLAU	9.10e-04	11	122	2	C0887799
Disease	Cerebral Infarction, Left Hemisphere	PLAT PLAU	9.10e-04	11	122	2	C0751010
Disease	Anterior Choroidal Artery Infarction	PLAT PLAU	9.10e-04	11	122	2	C0751012
Disease	Cerebral Infarction, Right Hemisphere	PLAT PLAU	9.10e-04	11	122	2	C0751011
Disease	Subcortical Infarction	PLAT PLAU	9.10e-04	11	122	2	C0751014
Disease	Cerebral Infarction	PLAT PLAU	9.10e-04	11	122	2	C0007785
Disease	thoracic aortic aneurysm (is_implicated_in)	THSD4 MMP9	9.10e-04	11	122	2	DOID:14004 (is_implicated_in)
Disease	Marfan Syndrome	MMP9 NOS2	9.10e-04	11	122	2	C0024796
Disease	pulmonary emphysema (is_implicated_in)	GSTM1 MMP9	9.10e-04	11	122	2	DOID:9675 (is_implicated_in)
Disease	obstructive sleep apnea (is_implicated_in)	SLC6A4 MMP9	9.10e-04	11	122	2	DOID:0050848 (is_implicated_in)
Disease	Thrombus	TYRO3 PLAT PLAU	9.19e-04	46	122	3	C0087086
Disease	diabetic maculopathy	USP7 ALK	1.09e-03	12	122	2	EFO_0010133
Disease	Pathological accumulation of air in tissues	ABCA3 NOS2	1.09e-03	12	122	2	C0013990
Disease	Pulmonary Thromboembolisms	PLAT PLAU	1.09e-03	12	122	2	C0524702
Disease	Pulmonary Embolism	PLAT PLAU	1.09e-03	12	122	2	C0034065
Disease	level of Phosphatidylinositol (16:0_18:1) in blood serum	RAPSN USP7	1.09e-03	12	122	2	OBA_2045152
Disease	Thrombosis	TYRO3 PLAT PLAU	1.11e-03	49	122	3	C0040053
Disease	lung disease (implicated_via_orthology)	MMP9 NOS2	1.28e-03	13	122	2	DOID:850 (implicated_via_orthology)
Disease	Erythrocyte Mean Corpuscular Hemoglobin Test	ACADVL AGL	1.28e-03	13	122	2	C0369183
Disease	osteitis deformans	DCSTAMP GSTM5	1.28e-03	13	122	2	EFO_0004261
Disease	bronchiolitis obliterans (is_marker_for)	MMP9 NOS2	1.28e-03	13	122	2	DOID:2799 (is_marker_for)
Disease	Finding of Mean Corpuscular Hemoglobin	ACADVL AGL	1.28e-03	13	122	2	C1261502
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	RAPSN USP24 GSTM1 SLC6A4 PMPCA LPA	1.36e-03	291	122	6	EFO_0008317, EFO_0020946
Disease	Liver Cirrhosis, Experimental	GSTM1 AGL PRKCD PLAT PLAU MME MMP9 TMEM184B NOS2 SLC37A4	1.43e-03	774	122	10	C0023893
Disease	skin melanoma (is_implicated_in)	GSTM1 MMP9	1.49e-03	14	122	2	DOID:8923 (is_implicated_in)
Disease	Diabetic Neuralgia	MME MMP9	1.49e-03	14	122	2	C0751074
Disease	Diabetic Neuropathies	MME MMP9	1.49e-03	14	122	2	C0011882
Disease	Hypothermia, natural	PRKCD NOS2	1.49e-03	14	122	2	C0020672
Disease	Asymmetric Diabetic Proximal Motor Neuropathy	MME MMP9	1.49e-03	14	122	2	C0271674
Disease	Symmetric Diabetic Proximal Motor Neuropathy	MME MMP9	1.49e-03	14	122	2	C0271673

Protein segments in the cluster

Peptide	Gene	Start	Entry
YWRGCNKIKSKGFPR	PTPRG	761	P23470
YRQLPAKWSGACVLG	ERV3-1	426	Q14264
KPAFKSQDCPWYDQG	CPSF4L	116	A6NMK7
KFLGYCPQENSLWPK	ABCA10	1281	Q8WWZ4
GKWHLGFYRKECLPT	ARSI	146	Q5FYB1
GAWCKDPLQAGDRIY	ADGRL1	161	O94910
SLIWRCGYSKAKQDP	EPHA5	616	P54756
SYWCGKPRAVAGKEE	ABCA3	491	Q99758
NAFILQGPKYKWICA	ECT2L	866	Q008S8
NPSFEKVPVGRYWKC	DHX29	396	Q7Z478
NFNKGDWIRVGLCYP	CEMIP	1071	Q8WUJ3
IDKGWCYKRVCVPFG	ADAMTS10	526	Q9H324
FKGHCIWKSPEQTYG	ADAMTS14	536	Q8WXS8
PCKAAELVNNYGKGW	RAPSN	186	Q13702
YSIVCLWASFGDPKK	RRH	256	O14718
GKPIRFGYKFWCGAT	ERCC6	756	P0DP91
RGKKWYSSPLLFCFE	ERCC6	946	P0DP91
FTQLCIDLGWKPKYG	NOS2	286	P35228
PLSGKYFSDCKRTWV	RDH12	276	Q96NR8
LGDKYACWYQQKPGQ	IGLV3-1	46	P01715
SDKKWGFCPDQGYSL	MMP9	381	P14780
ELKQWYKGFLKDCPS	HPCAL4	26	Q9UM19
YYQGKCLTWKGPRRQ	NCR3	161	O14931
KLYSEFLGKRPWFAG	GSTM5	136	P46439
WGLRCLKEQGYDPFK	NUDT15	136	Q9NV35
WCGMYNRFDKGLQPK	MTMR8	496	Q96EF0
KDFVWGLNKQGYKCR	PRKCD	176	Q05655
DDCWNGKGKSRYLFA	GPC4	421	O75487
RKKCPFQSWPEAYGS	IL17RE	256	Q8NFR9
NSWSKKYPSCGGLLQ	CA12	41	O43570
CELGRFGQKTGKGWY	EHHADH	566	Q08426
PDKKWVFACGTYSRT	FBXW12	241	Q6X9E4
FPQDYFPECKWSRKG	INPP5A	151	Q14642
MKRFLGPCGWKYENI	DCSTAMP	231	Q9H295
KDWFAARPDCGSKYQ	FBXO44	161	Q9H4M3
DKTKPLWHNYFLCGL	GALK2	101	Q01415
TDFFKYACGGWLKRN	MME	81	P08473
YACGGWLKRNVIPET	MME	86	P08473
VGKWECPFDEKGLVY	DNAH12	1816	Q6ZR08
KRGWKLQVSYDCRAP	PEG10	586	Q86TG7
LGFSGQLFKKWRDCP	LMLN2	311	A0A1B0GTW7
AWCRYGKREFKIGGE	LRATD2	206	Q96KN1
PGCRTLAKYGQRQWK	IL22RA2	91	Q969J5
EKGRRKCDQYWPADG	PTPRZ1	1831	P23471
CSAPFWGVVADRFKK	MFSD6	116	Q6ZSS7
DNCAFRLYGHWVKKG	PHKG2	351	P15735
ARPSVLWCYKKELGF	NAT10	51	Q9H0A0
WFLVKEGCYPASAGK	RELN	1331	P78509
KWYRVVPCGKRSFAV	GRIN3A	906	Q8TCU5
KWCYGNNVLRPGDKY	OBSCN	3216	Q5VST9
TCRVAGNPKPKIYWF	PALLD	1021	Q8WX93
KGGYWRRAQCDKQLP	PRG3	206	Q9Y2Y8
QYQWLEKVFGSCPRK	PSMG1	146	O95456
CGKVLRKWFEPSQFG	SLC37A4	121	O43826
ERKKFGPLGWNICYE	DNAH6	3701	Q9C0G6
WPLSKCFELKGNVYE	CASD1	581	Q96PB1
FNKGKSWEFGIPLCR	DOCK3	1301	Q8IZD9
LEKCDGWYRGFALKN	DOCK4	36	Q8N1I0
IFGKKCYLGDTWNRL	CACNA1G	141	O43497
SAKGFFRQYPGIKWE	CACNA2D3	216	Q8IZS8
GKKCYLGDTWNRLDF	CACNA1I	141	Q9P0X4
ELFPWRGYCSQKAKG	LDHD	11	Q86WU2
GWALAKCGGKNYERA	IFIT1B	146	Q5T764
WARCKVLYINGFTDP	LINC02902	111	Q6ZTY9
YRTFKNLGGNKDWCK	DHX33	566	Q9H6R0
IPGTNKWAGLEKNYC	LPA	1756	P08519
KWAGLEKNYCRNPDG	LPA	1761	P08519
TGHTYKFPCGRWLGK	DENND5A	1036	Q6IQ26
SNPEKWCPKDFGVRY	DENND2C	36	Q68D51
EDGSRWFGYCKKLLP	DENND2C	566	Q68D51
GWALLKCGGKNYERA	IFIT1	146	P09914
YRDFRGGQKKGWCTT	DNAI4	21	Q5VTH9
WGPAVYLCYKVGLAK	DENND4B	191	O75064
NFWCGITPKGFYKRT	COLGALT2	201	Q8IYK4
SKGCKVYFGRWLIEG	GYS1	96	P13807
LSWGKGQKDLLTPCY	HEXB	296	P07686
LGTCQTKPGQYWKEE	C9orf57	56	Q5W0N0
PKCSAKLGSFNWYGE	DUSP12	291	Q9UNI6
VGCNWLELPAGKYAL	POLD1	261	P28340
SIRGKKWYSSPLLFC	PGBD3	476	Q8N328
VPSGCKEGWNFYSNK	MRC1	941	P22897
PDTCRASIKGYQWLK	KCNAB3	301	O43448
ANTAGVGKWCKPYKF	FNDC8	261	Q8TC99
CARKYLLGVQPAWGS	PMPCA	266	Q10713
PCDRDYKKFWAGLQG	STAP2	31	Q9UGK3
VGYCQGAVWNKPTAK	PSAPL1	46	Q6NUJ1
WGRGCALKDKPGVYT	PLAU	396	P00749
ECPQYIRKKGADVWF	S100A8	41	P05109
WGKTYSIGFLRFCKQ	TMEM184B	161	Q9Y519
CNWDAKKGEYVFPAK	MOV10	596	Q9HCE1
FSCVGLNHKPKGKWY	ING1	381	Q9UK53
CDYFWADKKDPQGNG	GAS7	201	O60861
KLYSEFLGKRPWFAG	GSTM1	136	P09488
KFKNTCWIPGYSAGV	SIN3B	441	O75182
AVELCKNVKLYGFWP	ST8SIA6	331	P61647
SKCAWGKAGVDYAPN	TNS3	791	Q68CZ2
FKLGDDCRQKSYWGA	PI4KAP2	316	A4QPH2
KKSGFSPVRYGQCWV	TGM3	261	Q08188
PCGKYYTLNGSKLWI	ACADVL	236	P49748
SYYRKGGCAMLPVKW	ALK	1281	Q9UM73
NYWLGKKKPCITYGL	CNDP2	196	Q96KP4
GPLEHGQQWKKFLYC	C11orf97	41	A0A1B0GVM6
SNLKCLGLLEPYFWK	RNF17	1216	Q9BXT8
LGLLEPYFWKKGEAC	RNF17	1221	Q9BXT8
PYFWKKGEACAVRGS	RNF17	1226	Q9BXT8
WVKAGYKEPGIARCS	SLIT3	871	O75094
CEAEPKGKLWVNGYA	TNFAIP8L3	16	Q5GJ75
NPDRDSKPWCYVFKA	PLAT	181	P00750
KPYRCPECGKGFSWN	ZSCAN2	556	Q7Z7L9
ELKQWYKGFLKDCPS	VSNL1	26	P62760
AKWYPGCKYLLEQKG	XIAP	321	P98170
AERGYSWYKGQPKTC	ZCCHC3	321	Q9NUD5
NGKWFDKRCRDQLPY	CLEC3B	181	P05452
YRVLEKCQDGWFKGA	SH3RF3	491	Q8TEJ3
LQPFKGWALYCAGKA	SPR	161	P35270
RVYTGEKPYKCNEWG	ZNF137P	36	P52743
EKPYKCNEWGKALSG	ZNF137P	41	P52743
YWGCAIGKARQAAKT	PSMA3	161	P25788
GDYWKKIPGSVSCFT	TECPR2	1346	O15040
YAFLKGSCKWIRTPA	TMEM97	86	Q5BJF2
FGDKFKRPIGSWECS	NUP153	786	P49790
GCAWKNRPGVYTKVY	PRSS3	276	P35030
CSYFARDLWPKQGKK	ZNF492	46	Q9P255
CKLCGKAFFWPSLFR	ZNF442	211	Q9H7R0
QGIKPYRCSWCGKSF	ZNF75D	416	P51815
KDRRGCGKGKWYKFN	USP24	1976	Q9UPU5
WFDASRKGLYLCVGN	TSPEAR	286	Q8WU66
ARRYGPWFKGKDGNE	WSCD2	86	Q2TBF2
YEWEPFAEVKGNRKC	THSD4	331	Q6ZMP0
WRKICPIFKGIGYAI	SLC6A4	151	P31645
ASYDAWKKCLPIRGI	UBR4	4066	Q5T4S7
LKGVDLLRSWCYKGF	TTLL4	1061	Q14679
SWLYTFREKFPGKLC	TRIM62	436	Q9BVG3
VVYLNPKGDGKWCKF	USP7	466	Q93009
NYQWVKFDVCKPGDG	TBRG1	316	Q3YBR2
YRQGCASKLPVKWLA	TYRO3	686	Q06418
FCNSYSKDRGPWIVK	TTLL5	166	Q6EMB2
GSYFKVGERWYKPGC	ZAN	1486	Q9Y493
CWGDSVKLRYGNKPE	AGL	486	P35573